In 2022, UCB has expanded access to epilepsy medicines for several people in 8 underserved countries
Register to read the full analysis —or— Upgrade to access more features
#AccessToEducation
#Epilepsy
#EpilepsyTraining
#EpilepsyTreatment
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.